| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.29 | 6e-14 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.19 | 0.0003 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0009 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.092 | 0.001 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |